{"id":459254,"date":"2021-03-16T18:51:44","date_gmt":"2021-03-16T22:51:44","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=459254"},"modified":"2021-03-16T18:51:44","modified_gmt":"2021-03-16T22:51:44","slug":"genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/","title":{"rendered":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd."},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span> and SAN DIEGO<\/span>, March 16, 2021<\/span> \/PRNewswire\/ — Wolf Haldenstein Adler Freeman<\/span> & Herz LLP<\/a> announces that it is investigating GenMark Diagnostics (“GenMark”) (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark’s agreement\u00a0 to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05<\/span> per share.<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Wolf
\n <\/a>\n <\/p>\n<\/p><\/div>\n

If\u00a0you currently hold shares of GenMark,\u00a0please call Gregory Stone<\/span> at (800) 575-0735 or (212) 545-4774, or email to gstone@whafh.com<\/a>.<\/p>\n

\n
\n Wolf Haldenstein Adler Freeman<\/span> & Herz LLP<\/a> has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.\u00a0The firm has attorneys in various practice areas; and offices in New York<\/span>, Chicago<\/span> and San Diego.\u00a0The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.<\/p>\n

If you wish to discuss this investigation or have any questions regarding your rights and interests in this matter, please immediately contact Wolf Haldenstein<\/span><\/a> by telephone at (800) 575-0735, via e-mail at classmember@whafh.com<\/a>, or visit our website at www.whafh.com. <\/a><\/p>\n

Contact:
Wolf Haldenstein Adler Freeman<\/span> & Herz LLP
Gregory Stone<\/span>, Director of Case and Financial Analysis
Kevin Cooper, Esq.<\/span>
Email: gstone@whafh.com<\/a> or classmember@whafh.com<\/a>\u00a0
Tel: (800) 575-0735 or (212) 545-4774<\/p>\n

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman–herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-301248877.html<\/a><\/p>\n

SOURCE Wolf Haldenstein Adler Freeman<\/span> & Herz LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK and SAN DIEGO, March 16, 2021 \/PRNewswire\/ — Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics (“GenMark”) (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark’s agreement\u00a0 to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05 per share. If\u00a0you currently hold shares of GenMark,\u00a0please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to gstone@whafh.com. Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.\u00a0The firm has attorneys in various … <\/p>\n

Continue reading “GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-459254","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK and SAN DIEGO, March 16, 2021 \/PRNewswire\/ — Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics (“GenMark”) (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark’s agreement\u00a0 to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05 per share. If\u00a0you currently hold shares of GenMark,\u00a0please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to gstone@whafh.com. Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.\u00a0The firm has attorneys in various … Continue reading "GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd."\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T22:51:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.\",\"datePublished\":\"2021-03-16T22:51:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/\"},\"wordCount\":294,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/\",\"name\":\"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"datePublished\":\"2021-03-16T22:51:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/","og_locale":"en_US","og_type":"article","og_title":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk","og_description":"PR Newswire NEW YORK and SAN DIEGO, March 16, 2021 \/PRNewswire\/ — Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics (“GenMark”) (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark’s agreement\u00a0 to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05 per share. If\u00a0you currently hold shares of GenMark,\u00a0please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to gstone@whafh.com. Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.\u00a0The firm has attorneys in various … Continue reading \"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-16T22:51:44+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.","datePublished":"2021-03-16T22:51:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/"},"wordCount":294,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/","name":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","datePublished":"2021-03-16T22:51:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/459254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=459254"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/459254\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=459254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=459254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=459254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}